Chicago Partners Investment »

Esperion Therapeutics shares owned by Chicago Partners Investment

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Chicago Partners Investment from 13F filings

Historical chart of Chicago Partners Investment investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Chicago Partners Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Chicago Partners Investment

Quarter filed Position value Share count Share price at filing
2023-12-31 $31k 15k 2.03
2023-09-30 $24k 30k 0.80

More positions owned by Chicago Partners Investment

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p Mcp Etf (IJH)
Enterprise Products Partners (EPD)
Vanguard Index Fds Growth Etf (VUG)
Energy Transfer Com Ut Ltd Ptn (ET)
Dimensional Etf Trust Us Equity Etf (DFUS)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Rus Mdcp Val Etf (IWS)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Chicago Partners Investment

Top funds holding Esperion Therapeutics

Daniel D. Thurber
Vanguard Group
Bellevue Group
Meditor
Millennium Management
Two Sigma Investments
Two Sigma Advisers
Jpmorgan Chase & Co
Tang Capital Management
D. E. Shaw & Co
Walleye Trading
GSA Capital Partners
Schonfeld Strategic Advisors
Jacobs Levy Equity Management
Goldman Sachs Group

View all funds holding Esperion Therapeutics